Previously distributed by Taewoong Medical Co., Ltd., a Korean gastrointestinal medical device manufacturer, EUSRA and ELRA products will now benefit from Olympus' extensive global distribution network following its acquisition of Taewoong Medical. This collaboration marks a significant advancement for STARmed, facilitating accelerated market penetration and enhancing patient access to cutting-edge healthcare solutions worldwide.

Henry Shin, CEO of STARmed, expressed enthusiasm for the collaboration, stating, "Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy. We look forward to our products being made available to more patients through Olympus' global distribution network."

Mike Callaghan, Vice President and General Manager of GI EndoTherapy at Olympus, highlighted the superior quality and positive reception of STARmed's EUSRA and ELRA products. He affirmed Olympus' commitment to leveraging its market position to elevate the standard of care, fostering optimism for patients and healthcare providers globally.

The collaboration between STARmed and Olympus signifies a significant stride towards enhancing medical care delivery, underscoring a shared commitment to innovation and patient well-being. This partnership is poised to advance healthcare accessibility and quality on a global scale, promising a brighter future for patients worldwide